Tadalafil for painful bladder
Not Applicable
- Conditions
- Health Condition 1: N309- Cystitis, unspecifiedHealth Condition 2: null- Patients presenting with painful bladder syndrome, who are otherwise healthy
- Registration Number
- CTRI/2018/03/012720
- Lead Sponsor
- Dr Gajanan Bhat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the patients presenting with painful bladder syndrome who give their informed consent to participate in the study
Exclusion Criteria
1.DM
2.HTN
3.Mental disorders
4.Altered LFT/RFT
5.Patient on treatment for bladder pain syndrome
6.Patients with diagnosis of UTI, Malignancy etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change in symptom scores( using O�Laery-Sant IC symptom indices and numeric rating scale (NRS) for pain) and Change in bladder capacity using USG after 3 months of start of the study <br/ ><br>Timepoint: The change in symptom scores( using O�Laery-Sant IC symptom indices and numeric rating scale (NRS) for pain) and Change in bladder capacity using USG at the biginnning and after 3 months of the start of the study <br/ ><br>
- Secondary Outcome Measures
Name Time Method Drop out rate due to adverse events or worsening of the symptomsTimepoint: Beginning, every two weeks and end of the study